Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
FLGT
#2552
Fulgent Genetics, Inc. Common Stock
15.330
0
-35.79%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
-35.79%
Monthly Change
-43.64%
6 month change
-35.12%
Year Change
-35.12%
Previous Close
23.875
0
Open
15.330
0
Bid
Ask
Low
15.330
0
High
15.330
0
Volume
87
Markets
US Stock Market
Healthcare
FLGT
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
28.87 M
30.25 M
29.52 M
29.78 M
30.83 M
31.23 M
—
Valuation ratios
Enterprise value
1.42 B
2.89 B
828.73 M
777.74 M
518.35 M
775.51 M
2.34 B
Price to earnings ratio
5.85
6.14
6.62
-5.2
-13.1
-13.34
-54.28
Price to sales ratio
2.97
3.14
1.53
3.02
1.97
—
—
Price to cash flow ratio
8.91
5.79
3.74
32.31
26.52
7.95
400.85
Price to book ratio
2.2
2.69
0.75
0.77
0.49
0.73
1.13
Enterprise value to EBITDA ratio
4.83
4.2
3.92
-4.56
-10.41
—
—
Profitability ratios
Return on assets %
0.31
0.4
0.1
0.14
0.04
0.05
0.05
Return on equity %
0.38
0.44
0.11
0.15
0.04
0.05
0.05
Return on invested capital %
411.82
278.27
47.19
67
22.53
32.94
33.8
Gross margin %
78.7
78.29
59.28
36.12
37.82
40.56
162.02
Operating margin %
68.8
68.1
28.84
67.61
26.08
28.23
112.79
EBITDA margin %
69.51
69.21
34.12
-58.57
-17.28
-20.76
-82.81
Net margin %
50.82
51.12
23.17
58.03
15.07
18.75
74.83
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
4.02
5.81
7.13
6.96
4.85
6.48
25.82
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
1.07
1
0.46
0.22
0.23
0.27
0.27
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
0
0
0
0
0
0.01
Long term debt to total equity ratio
—
0.01
0
0
0
0
0.01
Per share metrics
Operating cash flow per share
5.85
17.39
8.19
0.91
0.7
3.3
3.31
EBIT per share
12.06
21.82
5.77
-6.56
-2.44
-2.96
-2.96
EBITDA per share
12.18
22.18
6.82
-5.69
-1.62
-2.18
-2.18
Total debt per share
—
—
—
—
—
—
—
Cash per share
12.44
5.32
2.57
3.27
1.82
10.92
19.8
Net current asset value per share
21.77
19.76
20.28
17.05
11.69
17.89
61.94
Tangible book value per share
23.67
34.61
31.42
32.6
32.29
30.99
125.46
Working capital per share
16.36
16.36
17.43
14.6
9.28
15.13
52.35
Book value per share
23.67
37.41
40.91
38.14
37.48
36.13
145.86
News
Netflix, Dell among market cap stock movers on Friday
Netflix and Dell among market cap stock movers on Friday
Fulgent Q4 2025 slides: EPS beats, but customer loss drives stock plunge
Fulgent Genetics, Inc. (FLGT) Q4 Earnings Top Estimates
Fulgent Genetics earnings beat by $0.22, revenue fell short of estimates
Brightspring Health Services, BASF, Swiss Re and more set to report Friday
Cheniere Energy to Report Q4 Earnings: What's in the Offing?
Doximity (DOCS) Q3 Earnings and Revenues Surpass Estimates
Fulgent Genetics (FLGT): The Price Has Caught Up To Value, But I Still Like The Stock
New Strong Buy Stocks for January 12th
FLGT to Acquire Bako & StrataDx Assets to Expand Pathology Platform
Fulgent Genetics to acquire Bako Diagnostics and StrataDx for $55.5 million